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Aim: N-acetyl-l-cysteine (NAC) is a free radical scavenger. We developed NAC coated Ag2S 
(NAC-Ag2S) QDs as an optical imaging and therapeutic agent. Materials & methods: QDs were 
synthesized in water. Their optical imaging potential and toxicity were studied in vitro. Results: 
NAC-Ag2S QDs produced with strong emission that is tunable between 748-840 nm, were stable 
in biologically relevant media. QDs showed significant differences both in cell internalization 
and toxicity in vitro. QDs were quite toxic to breast and cervical cancer cells but not to lung 
derived cells despite the higher uptake. NAC-Ag2S reduces reactive oxygen species (ROS) but 
causes cell death via DNA damage and apoptosis. Conclusion: NAC-Ag2S NIR QDs are stable 
and strong signal generating theranostic agents offering selective therapeutic effect.
Keywords: N-acetyl-l-cysteine (NAC), Ag2S quantum dots, imaging, apoptosis, reactive oxygen 
species (ROS), DNA damage
Introduction
Luminescent semiconductor nanocrystals (quantum dots, QDs) have received great 
attention in the last two decades, especially in bioimaging, biolabeling, diagnosis and 
therapy, with their excellent properties such as size-tunable emission, higher resistance 
against photobleaching, broader excitation and narrower emission spectra compared to 
organic fluorophores, which are commonly used in biological applications [1-3]. 
Recently, there is a great effort towards development of QDs with strong luminescence in 
the near-infrared region (NIR), since autofluorescence and absorption by living tissues are 
strong in the visible region of the spectrum.  Some cellular structures like collagen show 
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considerable autofluorescence and biological chromophores, in particular oxy- and 
deoxyhemoglobin cause luminescence quenching due to absorption and scattering of the 
light in the visible region [4]. Absorbance of water above 900 nm is also an important 
limitation. Hence, 700-900 nm region is accepted as the optical imaging window where 
the absorption coefficient of tissue is at its minimum and penetration depth of the light is 
higher [5, 6]. The most common NIRQDs which were tested for biolabeling, biosensing, 
in vitro and in vivo bioimaging applications are CdHgTe [7], CdHgTe/CdS [8], CdSeTe 
[9], and PbS [10]. Major road blocker for the transition of such QDs into the clinic is the 
potential health risks related to the presence of heavy metals in these compositions [11, 
12]. 
Ag2S QDs emerged as a new class of QDs with emission in the NIR region and became 
very popular with the highly biocompatible, stable and strongly luminescent nature [13-
16]. Very low solubility constant (Ksp = 6.3 x 10-50) inhibits the release of Ag+ ions into 
the biological media and ensures high biocompatibility [17]. In determining the 
biocompatibility of QDs, the organic coating around the crystalline QD core is also 
important. It does not only influence the QD-cell interaction, biodistribution and 
biocompatibility, but also it controls the particle growth, provide colloidal stability and 
surface functionality for the conjugation of desired ligands, peptides, drugs or 
oligonucleotides to QDs for specific action [18-20]. Ag2S QDs were synthesized with 
several functional coating materials in the literature such as 2-mercaptopropionic acid (2-
MPA) [16], dimercaptosuccinic acid (DMSA) which is a heavy metal chelator [21], 
bovine serum albumin (BSA) [22], polyethylene glycol [14], ribonuclease-A (RNase A) 
[17] or with mixed coatings such as polyethyleneimine (PEI)/2-MPA [15] and 
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PEI/cysteine [23]. These studies demonstrate the impact of coating on particle size, 
emission wavelength and toxicity. 
Use of biologically relevant molecules as a coating for QDs is a popular approach to 
render QDs less toxic. N-acetyl-l-cysteine (NAC), which is a derivative of cysteine, falls 
under this category. Emission tunable synthesis of NIR emitting CdTe/CdS capped with 
NAC via hydrodynamic route [24] and  folic acid tagged-NAC/CdTeS for targeted in vivo 
tumor imaging [25] are couple of examples to successful use of NAC as a coating material 
on QDs. Besides, inhibition of beta 1-40 amyloid fibrillation, which is one of the primary 
factors inducing Alzheimer’s disease, with NAC/CdTe QDs [26] and selective 
determination of 4c4   [27], copper [28] or Hg(II) [29] are some examples to different uses 
of NAC coated QDs from the literature.
NAC is a well-known antioxidant and a source of sulfhydryl group which is converted 
into metabolites in cells stimulating glutathione synthesis [30]. Hence, it is a natural 
scavenger of free radicals, especially reactive oxygen species (ROS), thereby it has been 
used as a pharmaceutical product in the diseases induced by free radicals [31-33]. NAC 
can be utilized to protect the tissues from the cytotoxicity of chemotherapeutic cancer 
drugs [34, 35]. NAC is also used to protect cells from oxidative stress and reduce QD-
induced cytotoxicity [36-38]. 
ROS have an important role in regulatory pathways [39]. Singlet oxygen (O.), 
superoxide [O2.-], hydroxyl radicals [.OH]), and peroxides (hydrogen peroxide [H2O2]) are 
the products of mitochondrial respiratory chain and are the constituents of ROS. In normal 
cells, ROS level is kept at a certain level while cancer cells have an abnormally high level 
of ROS [40]. QD based toxicity is, at least partially, attributed to ROS generation [36, 38]. 
Increasing ROS level is usually associated with cell death. However, downregulation of 
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ROS in apoptotic cancer cells was also reported for some antioxidants and NAC, as well 
[41, 42]. ROS scavenging effect of NAC was demonstrated in the literature [43-45]. 
However, bioavailability and stability of NAC is limited due the presence of reactive 
sulfhydryl group [43]. During the intravenous administration, NAC forms a disulfide bond 
with human serum albumin which limits its bioavailability [46]. One approach to improve 
its bioavailability is to render it more lipophilic and membrane permeable by forming its 
ethyl ester [47]  or amide derivative [48]. These approaches slightly improved the 
bioavailability of NAC in plasma. Conjugation of NAC to polymeric or dendrimeric 
carriers via a disulfide bond, which will cleave in vivo and release NAC, was reported to 
reduce ROS level more than the free NAC, which suggests better bioavailability via 
reduction of NAC-serum protein interaction [43, 49].
In this study, we synthesized highly luminescent, stable and NIR emitting NAC coated 
aqueous Ag2S QDs for the first time in the literature and evaluated the toxicity and 
imaging potential in several cell lines. Initially, variables such as the NAC amount, Ag/S 
ratio and reaction temperature was studied to produce the QDs with high colloidal 
stability and strong luminescence in biologically relevant media (pH 7.4 and pH 4.5 
dH2O, 10 mM NaCl, PBS and FBS). Later, cytotoxicity of NAC-Ag2S on several cell 
lines (A549, BAES-2, HeLa and MCF-7) was determined. An unprecedented therapeutic 
potential of NAC-Ag2S was discovered.  Influence of NAC-Ag2S QDs on ROS level, 
apoptosis and DNA-damage was examined on the most vulnerable MCF-7 cell line, in a 
dose and time dependent manner. Free NAC was also used for comparison. NAC-Ag2S 
emerged as a stable, effective optical label and a selective therapeutic agent. 
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Materials & methods
Materials
Silver nitrate (AgNO3, 99.9999%) and 2-(N-morpholino) ethanesulfonic acid (MES) 
were purchased from Aldrich (MO, USA). Sodium sulfide (Na2S) was purchased from 
Alfa-Aesar (Lancashire, England). N-acetyl-l-cysteine (NAC), sodium hydroxide 
(NaOH), acetic acid (CH3COOH), sodium chloride (NaCl), Suprapur nitric acid (65%) 
and Suprapur sulphuric acid (96%) were obtained from Merck Millipore (MA, USA). 
LDS 798 NIR laser dye was purchased from Exciton Inc. (OH, USA). Vivaspin 20 
centrifugal filters (3000 Da MW cut-off) were obtained from Sartorius (Goettingen, 
Germany). Roswell Park Memorial Institute 1640 medium (RPMI 1640, 1x), trypsin 
EDTA and penicillin-streptomycin solutions were provided by Multicell, Wisent Inc. 
(QC, Canada). Fetal bovine serum (FBS) was obtained from Capricorn Scientifc GmbH 
(Ebsdorfergrund, Germany). Thiazolyl blue tetrazolium bromide (MTT) and phosphate-
buffered saline (PBS) tablets were purchased from Biomatik Corp. (ON, Canada). 
Dimethyl sulfoxide Hybri-Max™ and 4′,6-diamidino-2-phenylindole (DAPI) were 
obtained from Sigma (MO, USA). 4% paraformaldehyde solution in PBS was purchased 
from Santa Cruz Biotechnology, Inc. (CA, USA). All 12-, 24- and 96-well plates were 
obtained from Nest Biotechnology Co. Ltd. (Wuxi, China). Only ultra-pure water (18.2 
MΩ, Rephile Biosciences and Technology, Shanghai, China) was used when water is 
needed. All reagents were of analytical grade or of the highest purity.
Synthesis of N-acetyl-l-cysteine coated Ag2S QDs
In a typical reaction, AgNO3 (0.125 mmol) and N-acetyl-l-cysteine (NAC) (0.25 mmol) 
were dissolved in 37.5 ml of deionized (DI) water in a reaction flask and pH of the 
Page 6 of 52
https://mc04.manuscriptcentral.com/fm-nnm
Nanomedicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
solution was adjusted to 10 using NaOH and CH3COOH solutions (1 M) under Ar flow. 
Na2S (0.03125 mmol) was dissolved in 12.5 ml of DI water in a separate 25 ml round-
bottom flask and sonicated under Ar flow for 30 minutes. Then, the Na2S solution was 
injected to the reaction mixture at 70°C under vigorous mechanical stirring (Figure 1). In 
order to follow the particle growth, 3 mL aliquots were taken from the reaction solution at 
different time points. At the end, reaction mixture was cooled down to room temperature 
(RT) and QDs were washed with DI water using Vivaspin 20 centrifugal filters.  Aqueous 
QDs are stored in the dark at 4°C.  
Reaction variables such as Ag/S, Ag/NAC, reaction temperature and reaction time were 
studied to understand their influence on the optical properties and stability of QDs. Table 
1 summarizes all recipes and the properties of the resulting QDs. 
In addition, dried QDs were dissolved in different biologically relevant media (pH 7.4 
and pH 4.5 dH2O, 10 mM NaCl, PBS and FBS) for the determination of their stability and 
optical properties in these media. 
Characterization Methods
All characterization methods are described in full detail in the associated 
Supplementary information document. 
Cell Culture
Human bronchial epithelial cell line (BEAS-2B), human lung adenocarcinoma cell line 
(A549) and human cervical cancer cell line (HeLa) were cultured in RPMI 1640 medium 
supplemented with 10% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin and 1% L-
glutamine. Human breast cancer cell line (MCF-7) was cultured in RPMI 1640 medium 
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containing 5% fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin and 1% 
L-glutamine. All these cell lines were incubated at 37°C under 5% CO2 atmosphere in a 
humidified  incubator. 
ATP viability assay
The luminogenic ATP assay was used to determine the level of cellular ATP as an 
indirect measure of the number of viable cells. Cytotoxicity of NAC-Ag2S QDs and free 
NAC at equivalent concentrations to NAC content of QDs (Supplementary Table 2) on 
MCF-7, A549, HeLa and BEAS-2B cells were determined by the ATP viability assay. All 
cells were seeded at a density of 5×103 cells per well with 100 µL of culture medium in 
96-well plates and allowed for cell growth for 24 h in a 37°C under 5% CO2 atmosphere 
in a humidified  incubator.. Then, cells were treated with QDs or free NAC in various 
concentrations (0.10–200 μg/ml) and incubated under same conditions for another 24 h or 
48 h. At the end of the incubation period, 50 μl of ATP-releasing reagent (a detergent-
based reagent) was added to each well and incubated at room temperature for 20–30 min 
to extract the intracellular ATP from the cells. 50 μl of this suspension from each well and 
50 μl luciferin–luciferase mixture per well (FLAAM, Sigma Aldrich, US) were transferred 
into a white opaque 96-well plate. Luminescence from each well was determined with a 
Bio-Tek Luminometer (USA). Viability of the treated cells was calculated with reference 
to the untreated controls.  All experiments were performed in triplicate.
Intracellular Uptake of QDs 
Intracellular uptake of NAC-Ag2S QDs was quantitatively determined from the 
intracellular Ag concentrations measured by ICP-MS (inductively coupled plasma–mass 
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spectroscopy). All cell lines were seeded at a density of 1.75×105 cells/well in 6-well 
plates and incubated for 24 h at 37°C under 5% CO2 humidified incubator. Then, cells 
were treated with NAC-Ag2S QDs at 100 µg/mL nanoparticle concentration and incubated 
for 1h. Cell media of each well were collected in separate tubes and attached cells were 
washed with 2 mL of PBS (pH 7.4). PBS used for the washing step was combined with 
the removed media from the cells. Then, attached cells were detached using 
trypsin/EDTA, transferred into a centrifuge tube and precipitated at 1500 rpm. After being 
washed with 4 mL of PBS in order to remove un-internalized QDs, precipitated cells were 
transferred into 10 mL volumetric flasks with 2 mL deionized water. The cell precipitates 
in the flasks were dried on a hot plate and treated with 1 mL acid mixture (ultrapure 
H2SO4 and HNO3 (1:9 v/v)) for at least 1 week. The cell lysates were diluted to 10 mL 
volume with deionized water and Ag ion concentration of the samples were measured by 
ICP-MS using a freshly prepared Ag standard curve. All experiments were repeated 4 
times and data is reported as the average. 
In order to evaluate the cellular uptake of QDs optically and demonstrate its imaging 
potential, QD treated cells were imaged under fluorescent microscope.  All cell lines were 
seeded into 6-well plates at a density of 1.75 x 105 cells/well and incubated under the 
same conditions described above. On the following day, cells were treated with NAC-
Ag2S QDs at a concentration of 100 µg/mL for 1 h and fixed with paraformaldehyde 
solution (4% in PBS) for 20 min after being washed with PBS three times. Then, the fixed 
cells were stained with the nuclear dye DAPI (1 µg/mL) and left in 2 mL PBS to keep the 
cells against drying. Cells were visualized using an Olympus-Xcellence RT Life Science 
microscope (Olympus, Tokyo, Japan) equipped with filters for DAPI (λexc: 352-402 nm 
and λem: 417-477 nm) and for QDs (λexc: 550 nm and λem: 650 nm long-pass filter). 
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Images were colored and merged using the ImageJ software (version 1.46r, NIH, USA) 
[50]. Untreated cells were used as controls. 
Determination of Apoptosis
Annexin-V staining was used to determine the apoptotic effect of NAC-Ag2S QDs and 
equivalent free NAC (Supplementary Table 2) on MCF-7 cells. Cells were cultured as 
1×105 cells/well in 6-well plates, treated with different concentrations of NAC-Ag2S QDs 
(0.78–200 μg/ml) or free NAC (0.29-73.2 μg/ml) and incubated for 48 h. At the end of the 
treatment, cells were collected. Early/late apoptosis and cell death was determined by 
using Annexin V/Dead Cell kit (MCH100105, Millipore, Darmstadt, Germany) according 
to the manufacturer's instructions. The live, dead, early and late apoptotic cells were 
counted using a Muse Cell Analyzer (Millipore, Hayward, CA, USA) (n=3). 
Induction of oxidative stress and ROS measurement
To evaluate the effect of different concentration of NAC-Ag2S QDs (0.78–200 μg/ml) 
and equivalent free NAC (Supplementary Table 2) on ROS generation, a ROS kit (Cat no 
MCH 100111-2; Millipore) was employed according to the manufacturer's protocol. A 
Muse Cell Analyzer (Millipore, Bedford, MA, USA) was used for the analysis. The 
Muse® Oxidative Stress Kit determines the count and percentage of cells undergoing 
oxidative stress based on the intracellular detection of superoxide radicals. Obtained 
results were confirmed with the cell-permeant 2',7'-dichlorodihydrofluorescein diacetate 
(H2DCFDA) assay (Sigma, cat #D6883). H2DCFDA is a chemically reduced form of 
fluorescein and used as an indicator for reactive oxygen species (ROS) in cells.  For this 
study, 5 x 103 cells were seeded into 96-well plates and incubated at 37°C under 5% CO2 
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atmosphere The following day, cells were pretreated with 5 mM of DCFDA (dissolved in 
PBS) for 2h. Then, 5 mM of DCFDA and test material (NAC-Ag2S QDs or free NAC) 
were simultaneously added to the cells. After 48 h incubation, emission from each well at 
535 nm (excitation=485 nm) was recorded using a micro-plate fluorometer (FLx800 Bio-
Tek, Vermont, USA). The experiment was performed in triplicate in each plate and in 
duplicate plates. 
 γH2A.X assay for the assessment of DNA damage
MCF-7 cells were exposed to NAC-Ag2S QDs (0.78–200 μg/ml) and free NAC (0.29-
73.2 μg/ml) for 48 h (Supplementary Table 2), separately. After detachment with 
trypsinization, cells were centrifuged at 300 × g for 5 min, washed once with PBS and 
fixed with the Muse Fixation Buffer, which is a component of the Muse γH2A.X 
Activation Dual Detection kit (MCH200101, Millipore, Darmstadt, Germany) for 5 min 
on ice. Then, cells were permeabilized by ice-cold Muse Permeabilization Buffer and 
incubated on ice for 5 min. These cells were centrifuged (300 × g, 5 min), resuspended in 
45 μL 1×assay buffer, and incubated with a mixture of 2.5 μL of antiphospho-Histone 
H2A.X and 2.5 μL of anti-Histone H2A.X, PECy5  for 30 min, in dark, at room 
temperature. At the end of the this incubation, cells were resuspended in 100 μL of 
1×assay buffer, centrifuged (300 × g, 5 min) and resuspended in 150 μL of fresh 1×assay 
buffer.  The levels of the Total protein and the phosphorylated H2A.X protein levels were 
measured using a Muse Cell Analyzer (Millipore, Hayward, CA, USA).
Statistical Analysis
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Non-parametric Kruskall–Wallis one-way analysis of variance followed by multiple 
Dunn’s comparison test of GraphPad Prism 6 software package (GraphPad Software, Inc., 
USA) was used for statistical analysis of the data. Comparison between two groups were 
performed using Mann-Whitney test. Only p-value < 0.05 was considered as statistically 
significant. All quantitative data were presented as mean values ± standard deviation 
(SD). All tests were two-tailed.
Results 
Synthesis and characterization of NAC-Ag2S QDs
NAC coated NIR emitting Ag2S QDs were prepared in a single step directly in water 
using AgNO3, Na2S and NAC at pH 10 where NAC is fully deprotonated to provide stable 
nanoparticles (Supplementary Figure 1). After the addition of Na2S to the reaction 
mixture, the color of the solution changed first to yellow-orange and then to brown. 
Variables, namely, Ag/S, Ag/NAC ratio, temperature and reaction time, were studied in 
detail to explore their effects on the particle properties including stability, size, emission 
wavelength and intensity. This allows determination of the best reaction recipe for the 
production of stable QDs with the strongest luminescence within the desired emission 
range and in small hydrodynamic sizes that are suitable for biomedical applications. 
First, NAC amount was studied as an independent factor. NAC-Ag2S were prepared at 
two different Ag/NAC mol ratio (1/2 (QD1) and 1/5 (QD4)) at fixed Ag/S ratio of 4/1 
(Table 1). Increased amount of NAC resulted in formation of larger crystals with 
absorbance onset at longer wavelength than QD1 (Figure 1A-B, Table 1). QD4 have a 
broader full-width at half-maximum (FWHM) with emission maxima centered at 823 nm 
with slightly stronger emission intensity (Figure 1A). In order to test if larger crystal size 
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observed with higher concentration of NAC is a result of partial decomposition of NAC, a 
control experiment without Na2S addition was performed (QD5) (Table 1).  However, 
neither a color change in the reaction (18 h), nor luminescence were detected in the 
reaction mixture confirming that NAC does not release sulfur under these conditions.
Next, Ag/S mole ratio was studied to tune the crystal size further and hence, emission 
wavelength of QDs. Two different composition with Ag/S ratio of 4/1 (QD1) and 2/1 
(QD2) at a fixed Ag/NAC ratio of 1/2 were synthesized at RT (Table 1).  As shown in 
Figure 1A-B, decrease in Ag/S ratio increased the crystal size and resulted in a red shift of 
emission maxima to 840 nm with a slightly enhanced luminescence intensity compared to 
QD1 (emission maxima at 748 nm). Indeed, the reaction times indicated in Table 1 
correspond to the time point where the strongest luminesce was obtained from that 
specific reaction. So, running the react on closer to the stoichiometry provided faster 
reactions, as well, reducing the required time from 90 to 30 min.
Table 1. Influence of reaction conditions on the properties of NAC-Ag2S QDs.
QD1 QD2 QD3 QD4 QD5
Ag/S (mol/mol) 4/1 2/1 4/1 4/1 4/0
Ag/NAC (mol/mol) 1/2 1/2 1/2 1/5 1/5
T (ºC) RT RT 70 RT RT
λabs(cutoff)a (nm) 683 795 719 778 ND
Sizeb (nm) 2.26 2.58 2.36 2.53 -
Band Gap (eV) 1.82 1.56 1.73 1.60 -
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λem(max) c (nm) 748 840 753 823 ND
FWHM (nm) 158 187 160 213
time (min) 90 30 30 30 18h
QY (%) NC NC 33 NC
Dhd (nm) 3.0 ± 1.3 2.6 ± 0.3 3.2 ± 1.0 NC
Zeta potential (mV) -41.6 ± 19.1 -51.4 ± 3.0 -35.3 ± 9.5 NC
aAbsorbance onset. bCalculated by Brus equation. c Emission maxima. d Hydrodynamic diameter measured by DLS 
and reported as the number average, NC : Not Calculated, ND : Not detected, RT : Room Temperature, FWHM : 
Full-width at half maximum of the emission peak.
Another variable that is influential in tailoring the crystal size and hence, the 
luminescence is the reaction temperature. Reactions with different Ag/S and Ag/NAC 
ratios were all performed at RT. Synthesis of QD1 was repeated at 70°C (QD3).  This 
caused a faster reaction, a small increase in the crystal diameter (from 2.26 nm to 2.36 
nm) and a small red shift in the emission maxima (from 748 nm to 753 nm) (Figure 1A 
and Table 1).  Most dramatic impact of higher reaction temperature was seen in the 
luminescence intensity providing the most strongly luminescing NAC-Ag2S QDs with 
33% quantum yield (QY, with respect to LDS-798 NIR dye) (Supplementary Figure 2). 
Therefore, this composition was used in further characterization of QDs and in the in vitro 
studies.
Photoluminescence lifetime measurements conducted with QD3 indicated a multiexponential 
luminescence decay with an average lifetime (Taverage) of 55.03 ns (Figure 2C). This is somewhat 
similar to lifetime values reported for other Ag2S QDs with different coatings in the literature 
[23, 50].  The faster component (T1) which arises from non-radiative events such as surface 
dangling bonds or electron-hole traps, which are considered as defects, was determined as 8.40 
Page 14 of 52
https://mc04.manuscriptcentral.com/fm-nnm
Nanomedicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
ns. The major component in this case is (B2: 78%) the slower component (T2=67.85 ns), which 
arises from the desired electron-hole recombination. 
The IR spectrum of NAC-Ag2S QDs (QD3) were recorded between 4000-650 cm-1 and 
compared with the free NAC. Strong bands at 1587 and 1390 cm-1 are typical for 
asymmetric and symmetric carboxylate stretching modes of NAC and confirm its 
existence in the QD coating (Figure 1D). The disappearance of the S–H stretching band of 
NAC at 2550 cm-1 suggests the binding of NAC to Ag2S core from its thiol group. The 
organic content of the QD3 was measured as 36.6% by Thermo Scientific Flash 2000 
Organic Elemental Analyzer (Supplementary Table 1).
TEM analysis of NAC-Ag2S QDs (QD3) indicates spherical nanoparticles with a size 
distribution between 1.45 nm and 5.20 nm (Figure 1E). EDX analysis of the nanoparticles 
shown in Supplementary Figure 3 confirmed the presence of Ag and S in QDs. Inter-
planar distance of the crystalline structure was 0.22 nm which agrees with the reported 
values for the [031] plane of monoclinic Ag2S (Figure 1F) [51, 52]. 
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Figure 1. Characterization of NAC-Ag2S QDs. (A) Photoluminescence and (B) absorbance 
spectra of NAC-Ag2S QDs synthesized under different conditions summarized in Table 1. (C) 
Time resolved photoluminescence decay curve of NAC-Ag2S (QD3). Black dots are scattered 
and red line is fitted data.  B1 and B2 represent amplitudes of fast and slow components, 
respectively. (D) FTIR spectrum of free NAC and NAC-Ag2S QDs, TEM images of the 
nanoparticles (E) at 5 nm scale and (F) focused lattice planes to determine the interplanar spacing 
and the corresponding plane.
Stability of NAC-Ag2S QDs in different media
In order to investigate their stability, NAC-Ag2S QDs (QD3) were suspended in a 
variety of biologically relevant media: dH2O at pH 7.4 and 4.5, 10 mM NaCl, phosphate-
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buffered saline (PBS) and fetal bovine serum (FBS).  The hydrodynamic size and the 
charge of QDs in these media would influence the blood circulation time and 
biodistribution [53]. The luminescence intensity of NAC-Ag2S QDs increases in FBS and 
PBS but no significant difference was observed in NaCl solution or at different pH values 
(pH 7.4 and 4.5) (Figure 2A). Absorbance of all these QD suspensions were identical 
except the FBS suspension which had a strong absorbance at 312 nm and a weak one at 
435 nm (Figure 2B). 
Hydrodynamic size and zeta potential of QDs in these media were determined 
immediately after the preparation of suspensions (0 hour) and after 2, 6, 12, 48 hours, to 
see if there is any precipitation or aggregation over time. The hydrodynamic size of the 
particles were quite similar in dH2O pH7.4 (3.33 ± 0.34 nm), dH2O pH4.5 (3.56 ± 0.90 
nm), 10 mM NaCl (3.61 ± 0.34 nm) and PBS (3.69 ± 1.84 nm) at the initial time point (0 
hour).  QDs in FBS have larger average hydrodynamic size (5.85 ± 0.27 nm). There was 
no precipitation in the solutions over time and the hydrodynamic size stayed relatively 
constant (Supplementary Figure 4, Figure 2C). The zeta potential of the nanoparticles was 
measured at different time points, as well (Figure 2D). QDs had a negative zeta potential: 
-38.5 ± 6.8 mV in dH2O pH7.4, -28.2 ±1.4 mV in 10 mM NaCl, -27 ± 6.2 mV in pH 4.5 
dH2O, -14.9 ± 3.8 mV in PBS, and -9.3 ± 0.7 mV in FBS indicating adsorption of the 
buffer or medium content on QDs in FBS and PBS. After 48 hours, zeta potentials were 
more negative:  -66.7 ± 3.1 mV in pH7.4 dH2O, -46.7 ± 0.2 mV in 10 mM NaCl, -45.6 ± 
4.0 mV in pH4.5 dH2O, -20.3 ± 1.1 mV in PBS and -10.1 ± 0.6 mV in FBS. 
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Figure 2. Influence of different media on photoluminescence (A), absorbance (B), 
hydrodynamic size (C) and zeta potential (D) of NAC-Ag2S QDs.
In vitro anti-growth activity of free NAC and NAC-Ag2S QDs 
To evaluate the anti-growth effect of NAC-Ag2S QDs (QD3), ATP viability assay was 
performed on MCF-7, HeLa, A549 and BEAS-2B cells after 24 h and 48 h incubation. 
NAC content of QD3 was determined by the Organic Elemental Analyzer and it was used 
for comparison in the experiments (Table S1). Concentrations of QD3 and the 
corresponding NAC amounts used in the in vitro studies are given in Table S2. As can be 
seen in Figure 3A and Figure 3B, free NAC did not affect the cell viability significantly, 
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whereas NAC-Ag2S QDs effectively reduced cell viability in a time, dose and cell type 
dependent manner (Figure 3C and Figure 4D). The IC50 (half maximal inhibitory 
concentration) values were determined from the graphs in Figure 3A-D and summarized 
in Figure 3E. The most vulnerable cell line was determined as MCF-7 with an IC50 of 23.2 
µg/mL in 24 h incubation which sharply decreased to 1.3 µg/mL in 48 h. HeLa required 
63 and 14.8 µg/mL QD3 for IC50 in 24 and 48 h incubations, respectively. In case of 
BEAS-2B cells, 129 µg/mL QD3 was determined as IC50 but only after 48 h incubation.  
A549 cells responded differently to QD3: Only a slight decrease in the cell viability was 
seen in 24 h within the studied concentration range, which indeed became less after 48 h 
incubation. 
For the rest of the in vitro studies, MCF-7 cell line was used since it emerged as the 
most sensitive cell type to NAC-Ag2S QDs.
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Figure 3. Cell viability of different cell lines treated with free NAC (A-B) and NAC-Ag2S 
QDs (C-D) determined by ATP assay 24 h and 48 h after exposure. Data are expressed as 
mean ± SD. * denotes statistically significant differences in comparison with control: * 
(p<0.05) and ** (p<0.01), (n = 3). (E) IC50 values of NAC-Ag2S QDs in different cell 
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lines after 24 and 48 h incubation. (F) Intracellular quantification of NAC-Ag2S QDs in 
different cell lines by inductively coupled plasma-mass spectrometry (ICP-MS). QDs at 
100 µg/mL concentration were incubated with cells for 1 h. The data are expressed as 
mean ± SD (n = 4).
Intracellular uptake of NAC-Ag2S QDs and optical imaging 
Internalization of QDs by these different cell lines was determined quantitatively from the 
intracellular Ag ion concentration using ICP-MS and qualitatively by fluorescence microscope 
equipped with a NIR filter set. Cells were treated with 100 µg/mL of NAC-Ag2S QDs for 1 hour. 
For the ICP-MS measurements, they were detached and digested by an acid treatment. For the 
optical imaging, they were fixed and investigated under the microscope. Based on the 
intracellular Ag concentrations, BEAS-2B (human bronchial epithelial cells) and A549 (a cancer 
cell line of lung) showed the highest QD internalization. Interestingly, these two cell lines 
showed the highest viability when treated with NAC-Ag2S QDs. MCF-7 and HeLa cells 
internalized QDs in much lower amount. . HeLa showed the least QD uptake (Figure 3F). 
Internalization of QDs by these cells was also confirmed using fluorescence 
microscopy (Figure 4). Luminescence of QDs can be clearly noticed by NIR signal 
detected in the cytoplasm of the cells. This indeed indicates that NAC-Ag2S QDs are 
promising optical imaging probes. The most intense optical signal was detected in BEAS-
2B cells and the lowest emission was observed in HeLa cells, which is in agreement with 
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the ICP-MS results. This suggests that NAC-Ag2S QDs may be a selective theranostic 
nanoparticle for some cancer types. 
Figure 4. Fluorescent microscopy images of MCF-7, Beas-2B, HeLa and A549 cells after 
1 h incubation with NAC-Ag2S QDs at 100 μg/ml concentration. DIC: differential 
interference contrast; DAPI: 4′,6-diamidino-2-phenylindole; NIR: Near-infrared images. 
Blue emission shows DAPI nuclear staining and red emission originates from emission of 
QDs. 
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Apoptosis-inducing effect of NAC-Ag2S QDs
Significantly reduced cell viability of MCF-7 cells by NAC-Ag2S was investigated 
further. The apoptotic potential of NAC-Ag2S QDs (0.78–200 μg/ml) and equivalent free 
NAC (0.29-73.2 μg/ml) were evaluated by using Annexin V/Dead Cell assay in MCF-7 
cell line (Figure 5 and Supplementary Figure S5). Cells treated with free NAC showed a 
very high fraction of live cells in the entire concentration range with no significant dose 
dependence: 90.60% live cells at 0.29 μg/ml and 89.10% at the highest concentration 
(73.2 μg/ml). On the other hand, fraction of live cells are 31.60% even at the lowest 
concentration (0.78 μg/ml) and 2.70% at the highest concentration (200 μg/ml) of NAC-
Ag2S QDs. Rest of the cells are either in the early and late apoptotic stage or dead. 
Overall, NAC-Ag2S QDs increases the p rcentage of total apoptotic MCF-7 cells that 
were mainly in the late apoptosis, which increases further with the increasing dose. For 
example, 13.85% of the cells are dead, 52% are late apoptotic/dead and 2.55% are early 
apoptotic cells at 0.78 μg/ml concentration of NAC-Ag2S QDs, while these numbers are 
53.15%, 44% and 0.15% at 200 μg/ml QD.  
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Figure 5. Determination of apoptosis in MCF-7 cells treated with NAC-Ag2S QDs (B-C) 
or free NAC (D-E) for 48 h and assessed by Annexin V/Dead Cell assay using flow 
cytometry. Percentages of cells were presented in each quadrant. (A) Control; (B) 0.78 
µg/mL and (C) 200 µg/mL of NAC-Ag2S QD; (D) 0.29 µg/mL and (E) 73.2 µg/mL of 
free NAC treated cells.
ROS downregulation of NAC-Ag2S QDs 
Since ROS is usually associated with apoptosis, and NAC is a well-known antioxidant 
and free radical scavenger, the influence of NAC-Ag2S QDs and free NAC on ROS levels 
was studied with two independent assays in a broad concentration range (0.78-200 μg/ml). 
First, a standard ROS kit was used and intracellular ROS levels were determined by 
flow cytometer. In the results shown in Supplementary Figure S6, “M2” represents the 
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percentage of cells with an increased production of ROS. When compared with the 
control, there are significant reductions in the ROS level at 100 and 200 µg/mL QD. M2 
values drop down to 2-5% from 10%, respectively. Influence of free NAC on the ROS 
level is not as significant as in the case of QDs, but there is some fluctuation in the data. 
So, a second method, DCFDA assay which uses a cell permeable fluorescent reagent, 
2’,7’-dichlorofluorescin diacetate, was used to measure the ROS level [54]. This method 
also confirms that NAC-Ag2S QDs decrease the ROS amount in MCF-7 cells at and above 
50 µg/ml concentration while no significant ROS reduction was seen with free NAC 
within the studied dose range (0.037-73.2 μg/mL) (Figure 6). So, conjugation of NAC 
onto nanoparticles increases its ROS scavenging effect.
Figure 6. ROS downregulation by NAC-Ag2S QDs and equivalent free NAC in MCF-7 
cells measured by DCFDA assay 48 h after the exposure. Data represents mean ± SD of 
three independent experiments (p < 0.05 (*), p < 0.01 (**)). 
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DNA damage 
The DNA damage in MCF-7 cells caused by NAC-Ag2S QDs and free NAC was 
evaluated by γH2A.X assay 48 h after treatment. As shown in Figure 7 and 
Supplementary Figure S7, H2A.X phosphorylation increases in a dose-dependent manner 
upon NAC-Ag2S QD exposure. The damage observed with free NAC appears to be much 
lower than NAC-Ag2S. γH2A.X  levels (shown as activated cells in Figure 7 and 
Supplementary Figure S7) in the NAC treated cells were between 4.5-16.5% in the whole 
concentration range while it increased to 17.40 - 66% in the QD treated cells. For the 
control cells , γH2A.X  level was about 5.6%.
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For Review OnlyFigure 7. γH2A.X levels in MCF-7 cells treated with NAC-Ag2S QDs (A and C) and 
NAC (B and D) measured by flow cytometry 48 h after treatment. (A) 0.78 µg/mL and 
(C) 200 µg/mL of NAC-Ag2S QD; (B) 0.29 µg/mL and (D) 73.2 µg/mL of free NAC 
treated; and (E) control cells. 
Discussion
Through a thorough study of reaction variables, an optimized recipe for the production of 
strongly luminescent Ag2S-NAC QDs with emission in the medical imaging window, 
small hydrodynamic size and stability in biologically relevant media was determined. 
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Synthesis of Ag2S-NAC QDs at Ag/S ratio of 4/1, NAC/Ag ratio of ½ at 70°C and pH 10, 
produced QDs with strong emission centered at 753 nm (FWHM=160 nm) with 33 % 
quantum yield, strong negative surface charge (-35.3 ± 9.5 meV) and small (3.2 ± 1.0 nm) 
hydrodynamic size.  By changing the variables, QDs with emission maxima between 748-
840 nm were obtained.  All produced particles are small, have a negative surface charge 
with zeta potential between ca -52 to -35 mV and all are colloidally stable.
The first reaction variable studied was the coating (NAC) amount. Increasing the NAC 
amount in the reaction from Ag/NAC ratio of 1/2 (QD1) to 1/5 (QD4), in otherwise identical 
conditions, caused production of larger crystals (2.26 nm versus 2.53 nm) exhibiting a red shift in 
emission maxima from 748 nm to 823 nm with a broader emission peak (FWHM 158 versus 213 
nm) (Table 1 and Figure 1A-B). Time required to achieve the strongest emission from the 
particles produced at higher NAC concentration was 30 min versus 90 min at low NAC 
concentration (Table 1) indicating a faster nucleation and growth at higher NAC concentration. 
Such increasing crystal size and faster growth kinetic may be due to the release of extra sulfur in 
case of decomposition of the coating molecule which would decrease the Ag/S ratio and the 
effective concentration of the coating material. Both of these would increase the crystal size. 
However, control reaction run in the absence of a sulfur source did not produce any Ag2S in 18h 
confirming that NAC does not decompose and change the stoichiometry of the reaction (QD5) 
but act only as a coating material.  Increasing amount of NAC in the reaction mixture may cause 
a crowding on the crystal surface or enhance intramolecular interactions limiting the earlier 
passivation of the growing crystal. 
Ag/S ratio is usually one of the major factors determining the crystal size. Decreasing 
Ag/S ratio from 4 (QD1) to 2 (QD2) shifted the emission maxima from 748 nm to 840 nm with a 
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slightly enhanced luminescence intensity (Figure 1A). Running reactions closer to the 
stoichiometry speeded up the kinetics (30 min versus 90 min) and produced larger crystals as 
expected with a band gap reduced from 1.82 eV to 1.56 eV corresponding to 2.26 and 2.58 nm 
crystals, respectively (Table 1). 
Reaction temperature affects the growth kinetics of nanoparticles and therefore, is another 
critical factor in controlling the crystal size and emission wavelength. All these reactions were 
performed at room temperature but when the recipe of QD1 was run at 70°C (QD3), slightly 
larger crystals (2.26 nm versus 2.36 nm) with a dramatically stronger emission  at slightly longer 
wavelength  (753 nm) were obtained in shorter reaction times (30 min) (Figure 1A and Table 1). 
As the temperature increases the stable crystal size increases as well, resulting in formation of 
larger crystals. At the same time, at higher growth temperature, better crystallization and mobility 
of surface atoms may provide a better quality of crystal surface with less surface defects, 
reducing the defect related non-radiative relaxation of the photogenerated electron and hole. This 
improves the emission intensity.
In this study, all produced particles were small, had a negative surface charge with zeta 
potential between ca -52 to -35 mV and were all colloidally stable (Table 1). Since NAC has a 
free carboxylic acid group, negatively charged QDs were expected. Therefore, all further 
characterization of QDs and the in vitro evaluations were performed with the most strongly 
luminescent NAC-Ag2S (QD3) with 33% quantum yield.
Coating of QDs are not only important in controlling the crystal size and colloidal 
stability but also, for luminescence properties. Dense and strong binding of the coating molecules 
on crystal surface eliminates surface defects, which are usually the major cause of weak 
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luminescence. Thiol containing structures like NAC show high binding affinity to crystal surface 
through their thiol groups and provide stable particles. Luminescence lifetime measurements 
indicated a multiexponential decay with the major contribution of the slower decay component 
(T2=67.85 ns) which is attributed to the electron-hole recombination rather than surface defects 
(Figure 1C). This finding supports the high quantum yield of these QDs.
Effective surface passivation was further supported by the FTIR analysis.  Absence of –
SH stretching band of  NAC at 2550 cm-1 along with the presence of typical carboxylate 
stretching peaks confirmed the presence of NAC, absence of free NAC and binding of NAC to 
Ag2S crystal from its thiol group (Figure 1D). Well passivated and stabilized QDs with strong 
negative surface charge had quite small hydrodynamic size in agreement with the crystal sizes 
calculated from the Brus equation (2.26-2.58 nm) and sizes measured from TEM images (1.45-
5.20 nm) (Figure 1E and Table 1). TEM images also prove crystalline, monoclinic Ag2S core 
with inter-planar distance of 0.22 nm (Figure 1F).
Both colloidal and luminescence stability of the QDs in biologically relevant media have 
a crucial importance for practical applications. The hydrodynamic size and the surface charge 
influence the blood circulation time and biodistribution of nanoparticles [53]. Hence, size, charge 
and luminescence of NAC-Ag2S QDs in dH2O at pH 7.4 and 4.5, mimicking the plasma and 
intracellular pH values, 10 mM NaCl and phosphate-buffered saline (PBS) which are common 
diluents for in vitro and in vivo studies and fetal bovine serum (FBS) which is a supplement in 
cell culture medium providing a combination of biologically relevant mixture of growth factors, 
proteins, vitamins, etc., were measured (Figure 2).  In a period of 48h, QDs stayed colloidally 
stable in each of these media and the hydrodynamic size stayed relatively constant with negative 
surface charge supporting the colloidal stability provided by electrostatic repulsion of particles. 
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Measurements were conducted at different time points with 48 h as the end point. This is mainly 
because 24 h and 48 h are comment incubation times in the in vitro studies and, in the in vivo 
studies 48h is usually enough for major organ distribution.  The strong negative zeta potential at 
pH 7.4 decreased at pH 4.5 due to partial protonation and in 10 mM NaCl due to some shielding 
in charge repulsion. However, in all of the studied media, QDs were negatively charged and 
provided colloidal stability (Supplementary Figure S4).
NAC has been reported to inhibit growth, proliferation and invasive behavior of human 
cancer cells, including colorectal [55], bladder [56, 57], prostate [58], tongue [59] and lung [60] 
carcinoma in vitro. Hence, first a dose dependent viability test was performed on MCF-7, HeLa, 
A549 and BEAS-2B cells after 24 h and 48 h incubation with QDs. ATP assay is a 
bioluminescence assay that uses recombinant firefly luciferase enzyme in order to quantify the 
amount of cellular ATP in the viable, metabolically active cells and gives more realistic results 
compared to frequently used MTT assay [61]. Results were compared with free NAC at the 
concentrations corresponding to the NAC content of QD3 (Figure 3A-B). NAC-Ag2S reduced 
cell viability more dramatically in MCF-7 and HeLA cells in a dose and time dependent manner 
with IC50 values of 23.2 and 63 µg/mL in 24 h, and 1.3 and 14.8 µg/mL in 48 h, respectively 
(Figure 3C-E). Lung derived cells behaved quite differently. There was no significant reduction 
in the viability of BEAS-2B cells in 24 h. Toxicity was observed after 48 h with a quite high IC50 
value of 129 µg/mL.  A549 cells seemed to be more vulnerable in 24 h than in 48 h exposure. At 
longer incubation times, cells might have developed some resistance to NAC-Ag2S QDs. 
However, in either case, even at the highest (200 µg /mL) QD concentration viability of A549 
cells was above 50%.  Free NAC at the corresponding concentrations did not induce significant 
toxicity in any of the cell lines in 24 h. However, up to 20% reduction in cell viability was seen 
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only at the highest three concentrations (18.3-73.2 µg /mL) after 48 h incubation (Figure 3A-B). 
Enhanced cytotoxicity or reduced cell viability at higher dose of QDs and/or longer exposure 
time is most probably related to increased uptake and time dependent intracellular kinetics.  
Overall, these findings imply that although NAC has no significant cytotoxicity to these cell 
lines, NAC-Ag2S QDs may induce significant toxicity in breast and cervical cancer cells. It is 
notable that cancerous or healthy lung cells behave differently and A549 cells are not 
significantly affected by NAC-Ag2S QDs.
It is important to evaluate such viability results along with the intracellular concentration 
of QDs. Based on the intracellular Ag concentrations measured by ICP-MS, BEAS-2B and A549 
internalized more QDs than MCF-7 and HeLa cells in this given order (Figure 3F).  These 
measurements were done after 1h incubation of the cells with QDs in order to have 100% cell 
viability, so that we would not lose the dead cells with may be more QD loading. The highest 
uptake was about 10 % of the loaded dose (100 g/mL QD). Interestingly, BEAS-2B and A549 
cells showed the highest viability despite of the higher uptake, which indicates a significant 
cytocompatability of these QDs in these lung derived cell lines. MCF-7 and HeLa cells 
internalize much less QDs (in the order of 4.5 and 2%) but are the more vulnerable ones, which 
indicates significant cytotoxicity of NAC-Ag2S QDs in these cell lines. 
Fluorescence images of the cells treated with QDs indicate cytoplasmic distribution of QDs in 
each cell line (Figure 4). BEAS-2B cells with the highest amount of QD load provided a very 
strong optical image but HeLa cells with low level of QDs showed a very weak NIR signal, 
which is in agreement with the internalization data. Selective uptake coupled with selective 
toxicity may provide numerous opportunities in the utilization of NAC-Ag2S QDs as a selective 
theranostic nanoparticle for certain cancer types. 
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While NAC was usually used to reverse or reduce the ROS based toxicity of QDs in the 
literature, it is also reported to have pro-apoptotic effects on cancer cells. For instance, Amini et 
al. demonstrated cell cycle inhibition and induction of apoptotic cell death by NAC in the 
gastrointestinal carcinoma cells [62]. Nargi et al. reported a similar involvement of NAC in cell 
cycle arrest or apoptosis in a range of colorectal cancer (CRC) cell lines [55]. Guan et al. 
suggested that NAC induces apoptosis via endoplasmic reticulum stress and unfolded protein 
response pathways in HeLa cells [63]. In several other studies, NAC was reported to induce 
apoptosis in aortic smooth muscle cells or p53-mediated apoptosis in several oncogenically-
transformed fibroblasts but not in endothelial cells or in normal cells [64-66]. Therefore, the 
apoptotic cell death caused by NAC-Ag2S QDs was evaluated in the full concentration range of 
0.78–200 μg/ml by using Annexin V/Dead Cell assay in the most vulnerable MCF-7 cell line 
(Figure 5 and Supplementary Figure S5). It is clear that as the concentration of QDs increases, 
the amount of apoptotic cells increases, and at the highest concentration (200 μg/ml) 53.15% of 
the cells were dead, 44% were late apoptotic/dead and 0.15% were early apoptotic cells.   Major 
changes seems to occur between 3-6 μg/ml and 50-100 μg/ml doses (Supplementary Figure S5). 
These results clearly indicate that NAC-Ag2S QDs induce a dose dependent apoptosis in MCF-7 
cells while about 90% of cells were live in the whole concentration range (0.037-73.2 g/mL) of 
free NAC. Choi et al. showed significant toxicity of NAC capped or NAC conjugated CdTe on 
human neoroblastoma cells at the dose of 5 μg/mL in 24 h [36]. However, they claim that NAC-
CdTe has lower cellular uptake and hence are less toxic compared to cationic cysteamine coated 
CdTe. The IC50 values for the four cell lines studied here are much higher than this concentration. 
So, in a way NAC-Ag2S is much safer than NAC-CdTe, at least partially due to Cd-free nature. 
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ROS is a very important factor associated with apoptosis and NAC is a well-known 
antioxidant and free radical scavenger. Therefore, it has been used to reverse the QD 
based toxicity in the literature. In two different methods used for the determination of 
ROS levels in MCF7 cells exposed to QDs or free NAC, it was clearly seen that NAC-
Ag2S QDs reduced ROS level much more effectively than free ROS, especially above 50 
µg/ml concentration (Figure 6). Typically, NAC is used between 0.0408-1.306 mg/mL 
(0.25 mM-8 mM) concentration range for suppression of ROS in the literature [43, 67]. 
Here, the studied dose of free or bound NAC is 0.037-73.2 g/mL. So, conjugation of 
NAC onto nanoparticles increases its ROS scavenging effect probably by improving its 
uptake as also shown in other reports [43, 49, 67].  This is interesting since NAC-Ag2S 
lacks free sulfhydryl group, and QDs were stable in lysosomal pH.  Downregulation of 
ROS along with the enhanced apoptosis in MCF-7 cells  may be supported by some 
reports on reduced ROS production and Akt phosphorylation by NAC in breast cancer 
cells, resulting in apoptotic cell death [42] and NAC associated enhancement of H2O2, UV 
and MK886 induced apoptosis of murine hybridoma [68], human melanoma [69] and 
human T-cell leukemia cells [70]. 
Another route for cell death is DNA damage, which was studied by γH2A.X assay in this 
study. Elevated levels of γH2A.X  (shown as activated cells in Figure 7 and Supplementary 
Figure S7) in the QD treated MCF7 cells (17.40 – 66 %) compared to NAC treated cells  (4.5-
16.5 % ) and the control (5.8 %) indicates that NAC-Ag2S causes a significant DNA damage 
compared to free NAC. This suggest that the DNA damage is ROS independent. There are many 
studies demonstrating that ROS is not required for DNA damage [71, 72].
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Conclusion
In this study, we present a simple, one-step aqueous synthesis and detailed 
characterization of NAC-Ag2S QDs. NAC is bound to the crystal surface via S-Ag bonds 
providing stable nanoparticles. By varying the synthetic recipe, the wavelength of the 
emission maxima was tuned between 750-840 nm, which is within the recommended 
optical imaging window.  The most luminescent composition have 33% QY. QDs have 
ultrasmall hydrodynamic size, which is valuable for further functionalization and 
prolonged blood circulation. All QDs have strong negative surface charge and excellent 
colloidal and optical stability in different, biologically relevant media and pH values 
including the physiological pH and endosomal acidic pH.  
NAC-Ag2S QDs were well internalized by several different cell lines, MCF-7, HeLa, 
A549 and BEAS-2B and generated a significant intracellular signal proving its potential 
as an optical imaging agent or a luminescent label. 
In vitro cytotoxicity evaluation of NAC-Ag2S QDs in these four different 
cancerous or healthy cells in a broad concentration range (0.1-200 μg/ml corresponding to 
0.037-73.2 μg/ml free NAC) showed that NAC-Ag2S QDs reduce viability of MCF-7 and 
HeLa  cells significantly while free NAC did not induce much cell death. This is quite an 
interesting result and should originate from the NAC coating since Ag2S coated with 
different materials such as 2MPA or DMSA showed no toxicity to similar cells (MCF7 
and HeLa) even at much higher doses [16, 21]. It is quite interesting that such high 
cytoctoxicity to MCF7 and HeLa cells is not correlated with higher cellular uptake since 
A549 and BEAS-2B internalized more QDs but were not affected as much as the other 
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tumor cell lines. A549 seems to be quite resistant and toxicity was seen in BEAS-2B 
mostly after 48h. In fact, this differential cytotoxic activity on different tumor types is 
highly desirable for an anticancer agent since it indicates organ/tissue-specific activity of 
QDs. Therefore, NAC-Ag2S QDs may be a good candidate for an investigational new 
drug (IND).   Indeed, higher uptake by lung based cells coupled with lower toxicity to 
these cell lines is also interesting and deserves further investigation by experts in the field. 
Lung cells (normal or cancerous) may have higher level of oxidative stress, which results 
in the utilization of NAC more rapidly compared to the breast or cervix cells. Indeed, 
NAC is used in obstructive pulmonary disease to reduce symptoms and exacerbations as 
an adjunct therapy [73, 74]. It is reported for activity in lung cancer prevention, as well 
[75]. This may be due to its antioxidative (or unknown) properties because oxidation is 
known to damage DNA that results in mutations, thereby cancer, over time. 
Further studies performed with the most sensitive cell line, MCF-7, showed that NAC-
Ag2S QDs suppress ROS level, even more effectively than free NAC, and trigger DNA 
damage-induced apoptosis. This is also interesting considering that NAC is conjugated to 
nanoparticles from the thiol units, which has the primary role in radical scavenging. One 
example in the literature, which states significant toxicity of NAC-CdTe in neuroblastoma 
cells did not specify the origin of such toxicity [36]. This needs further investigation, 
which is beyond the scope of the current study.
Overall, in this study, not only highly stable and strongly luminescent NAC-Ag2S QDs 
were developed, but also its potential as a theranostic QD in selected cancer cells/types 
was discovered. 
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Future Perspective
NAC coated Ag2S is produced for the first time and in vitro cytotoxicity studies revealed that 
NAC does not render QDs non-toxic for each and every cell line. Its safety is dose and cell type 
dependent. This should encourage researchers, who uses biomolecules as safe coating 
alternatives, to perform their studies in a broader dose range with a wider selection of cell lines.  
Besides, selective uptake and cytotoxicity of these QDs is quite unexpected hence, will initiate a 
new research to investigate the origin of this selectivity and its utilization for lung cancer. 
Considering that 2D cell studies are actually not perfect models to make firm conclusions, we 
plan to investigate their selectivity and theranostic potential with animal studies. 
Summary Points
o The main aim of this study is to develop NIR emitting NAC coated aqueous Ag2S 
QDs as optical imaging and therapeutic agent. 
o We demonstrated for the first time the synthesis of highly stable, NAC coated 
Ag2S QDs with a strong emission tunable between 748-840 nm with quantum 
yield as high as 33%.
o NAC coated Ag2S QDs have small hydrodynamic sizes and strong negative 
surface charge as well as excellent colloidal and optical stability in different 
media and pH values. 
o In vitro cytotoxicity studies performed in a broad dose range (upto 200 g/mL 
QD) showed that although NAC is not toxic, NAC-Ag2S QDs may be quite toxic.
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o In the in vitro studies NAC-Ag2S QDs showed selective toxicity in human breast 
cancer (MCF-7) and cervical cancer (HeLa) cell lines compared to lung 
adenocarcinoma (A549) and bronchial epithelial (BEAS-2B) cells. 
o NAC-Ag2S QDs were internalized more by A549 and BEAS-2B cells than MCF-7 
and HeLa cells but were not as toxic to lung based cells.
o Detailed in vitro studies on the most sensitive cell line, MCF-7, demonstrated 
that NAC-Ag2S QDs suppress ROS level even more than free NAC.
o NAC-Ag2S QDs trigger DNA damage-induced apoptosis in MCF-7 cell line.
o NAC-Ag2S QDs generated a strong intracellular signal in NIR region of optical 
spectrum and proved their potential as an effective optical imaging agent. 
o NAC-Ag2S QDs emerged as a good candidate for an investigational new drug 
with diagnostic potential.   
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Supplementary Information
Development of NIR luminescent N-acetyl-L-cysteine coated Ag2S 
quantum dots with differential therapeutic effect 
Characterization methods
The absorbance spectra of the quantum dots were recorded using a Shimadzu UV-Vis-NIR 
spectrometer in the 500–1100 nm range. Photoluminescence spectra in the near-infrared region 
were recorded using a homemade set up : a 1/8 Newport Cornerstone 130 monochromator equipped 
with a 600 L mm-1 grating which works in the 400–1100 nm scale, a femtowatt sensitive Si detector 
(Thorlabs PDF10A, 1.4 x 10-15 W Hz-1/2) and a frequency doubled output of a DPSS laser (532 
nm). Measurements were performed with 0.5 mm slit width and a 590 nm long pass filter. Brus 
equation (Eq. 1) was used to calculate the crystal sizes of Ag2S nanoparticles from the absorption 
edge found from the absorption spectra of QDs [49, 50]. 
                                                                                 (Eq. 1)∆𝐸 =  ℏ2𝜋28𝑅2  [ 1𝑚𝑒 +  1𝑚ℎ] ―1.8 𝑒2𝜀𝐴𝑔2𝑆4𝜋𝜀0𝑅
In Eq. 1, R is the radius of the Ag2S, me  (=0.286 m0 )is effective electron mass and mh (=1.096)is 
hole mass of inorganic core,  (5.95) is the dielectric constant and ΔE is the band gap energy 𝜀𝐴𝑔2𝑆
difference between the nanocrystal and the bulk  Ag2S[51]. 
Quantum yield (QY) of the QDs was calculated based on the procedures in the literature 
using LDS 798 NIR dye (QY 14% in methanol, reported by the producer) as a reference [21, 23]. 
Five different concentrations of the dye were prepared in methanol  and aqueous NAC-Ag2S QDs 
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with absorption below 0.10 at the excitation wavelength (532 nm) were prepared. The PL spectra 
of all concentrations were recorded and integrated areas under the emission peaks were plotted 
against the concentrations. QY was calculated from the ratio between the slope of the sample (mQD) 
and the slope of the dye (mstandard) using the refractive index (η) of water and methanol as follows: 
                                                                                  (Eq. 2)QYQD = ( mQDmstandard)( ƞwater2ƞmethanol2) × 100
Fluorescence lifetime analysis was performed using a Horiba Fluorolog equipped with 
TCSPC Triple Illuminator. 456 nm Horiba Nanoled pulsed diode light source (pulse duration 
1.2 ns) was employed. Measurement time of 400 ns was taken for 4096 channel to obtain high-
resolution measurements.
Hydrodynamic size and zeta potential of the aqueous nanoparticles were measured using a 
Malvern Zetasizer Nano-ZS. Organic elemental analysis was performed by a Thermo Scientific 
Flash 2000 Organic Elemental Analyzer. 2-3 mg dried sample and vanadium pentoxide which is a 
typical oxygen donor that allows the total conversion of sulphur, were placed into a tin capsule and 
loaded to the combustion reactor via the Thermo Scientific MAS 200R autosampler. To calculate 
the organic elemental content of the sample, a standard curve drawn by 2,5-bis-(5-tert-butyl-2-
benzoxazol-2-yl) thiophene (BBOT) was used. 
Particle shapes and morphologies were determined by a transmission electron microscopy 
(TEM Philips-FEI-Tecnai G2 F30) operating at an accelerating voltage of 200 kV. Fourier 
transform infrared (FTIR) spectra of the QDs were taken on a Thermo Scientific Nicolet iS10 FT-
IR 4000-650 cm-1, single reflection diamond ATR spectrometer. Ag+ content in QDs was measured 
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using an Agilent 7700×ICP-MS (inductively coupled plasma–mass spectroscopy). NAC-Ag2S 
QDs were digested with 1 mL of acid mixture including suprapur sulphuric acid and suprapur nitric 
acid (1:9, v/v), and then diluted to 10 ml with DI water in a volumetric flask for the ICP 
measurements.
Table S1. 
Organic elemental analysis of NAC-Ag2S QDs measured by Organic Elemental Analyzer
Element Weight 
%
Nitrogen 3.3
Carbon 20.2
Hydrogen 2.4
Sulphur 10.7
Totals 36.6
Table S2.  
Equivalent concentrations of free NAC to NAC-Ag2S QDs.
NAC
(µg/mL)
0.037 0.073 0.14 0.29 0.57 1.15 2.29 4.58 9.15 18.3 36.6 73.2
NAC-Ag2S
(µg/mL)
0.10 0.20 0.39 0.78 1.56 3.13 6.25 12.5 25 50 100 200
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Fig. S1. Aqueous synthesis of NAC-Ag2S QDs. 
Fig. S2. Plot of the integrated luminescence intensities of the reference dye, LDS 798, and NAC-
Ag2S QDs against the absorbance intensities. Inset shows the slope of each line corresponding to 
the dye and NAC-Ag2S. 
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Fig. S3. EDX analyses of NAC-Ag2S QDs (QD3). 
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Fig. S4. Time dependent colloidal stability of  NAC-Ag2S QDs in different media. (a) in dH2O, 
pH7.4; (b) in dH2O, pH4.5; (c) in 10 mM NaCl; (d) in PBS; (e) in FBS. 
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Fig. S5. Determination of apoptosis in MCF-7 cells treated with NAC-Ag2S QDs or free NAC for 
48 h and assessed by Annexin V/Dead Cell assay using flow cytometry. Percentages of cells were 
presented in each quadrant.  
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Fig. S6. Intracellular ROS level of MCF-7 cells treated with NAC-Ag2S QDs or equivalent free 
NAC, measured by ROS kit and flow cytometer 48 h after the exposure. Data represents mean ± 
SD of three experiments (p < 0.05(*), p < 0.01 (**)).  
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Fig. S7. γH2A.X levels in MCF-7 cells treated with NAC-Ag2S QDs and NAC measured by flow 
cytometry 48 h after treatment.
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